[EN] TREATMENT OF ISCHEMIC EYE DISEASE BY THE SYSTEMATIC PHARMACEUTICAL ACTIVATION OF HYPOXIA INDUCIBLE FACTOR (HIF)<br/>[FR] TRAITEMENT D'UNE MALADIE ISCHÉMIQUE DE L'OEL PAR ACTIVATION PHARMACEUTIQUE SYSTÉMATIQUE D'UN FACTEUR INDUIT PAR L'HYPOXIE (HIF)
申请人:CLEVELAND CLINIC FOUNDATION
公开号:WO2009035534A2
公开(公告)日:2009-03-19
The present invention consists of a method of treating a subject with an ischemic eye disease associated with the down-regulation of HIF comprising administering to the subject an effective amount of a compound that induces HIF activity and/or induces EPO activity to induce and maintain growth or normal retinal blood vessels in the early stage of the disease.